Dr. Eric Sanchez -- Pharmaceutical Payment Report

This page provides a comprehensive transparency report for Dr. Eric Sanchez, a Internal Medicine physician based in Athens, GA. All payment data is sourced from the CMS Open Payments (Sunshine Act) database. Dr. Eric Sanchez has received $12.66 in total pharmaceutical industry payments across 1 transactions from 1 pharmaceutical companies.

Physician Profile

The following profile information is sourced from the National Provider Identifier (NPI) registry and CMS Open Payments records.

  • Full Name: Dr. Eric Sanchez
  • Medical Specialty: Internal Medicine
  • Practice Location: Athens, GA, Georgia
  • NPI Number: 1767530923
  • Transparency Score: 50/100
  • Payment Records Span: 2026-03-08 to 2026-03-08

Payment Summary

Dr. Eric Sanchez has received a total of $12.66 in pharmaceutical industry payments across 1 recorded transactions in the CMS Open Payments database. The average payment amount is $12.66 per transaction.

  • Total Payments Received: $12.66
  • Number of Transactions: 1
  • Average Payment: $12.66
  • Transparency Score: 50/100 -- This score reflects the overall payment profile relative to peers in Internal Medicine. A higher score indicates fewer or more routine payments.
  • Number of Pharma Relationships: 1 pharmaceutical companies
  • Drugs/Devices Referenced: 1 distinct products

Payment Breakdown by Category

The following table shows how Dr. Eric Sanchez's pharmaceutical payments break down by payment category. Understanding the mix of payment types provides important context about the nature of the doctor-pharma relationship.

Payment CategoryAmountDescription
Food & Beverage$12.66Meals and refreshments during sales visits, meetings, and events

The largest payment category for Dr. Eric Sanchez is Food & Beverage, accounting for 100% ($12.66) of total pharmaceutical payments received. This is the most common type of pharmaceutical payment and typically involves meals provided during sales representative visits.

Pharmaceutical Company Relationships

The following pharmaceutical and medical device companies have made payments to Dr. Eric Sanchez. Click on any company name to view their full physician payment profile and spending patterns.

CompanyTotal PaidTransactions
Biogen$12.661

Dr. Eric Sanchez has a financial relationship with Biogen, receiving $12.66 in total. Having a single pharmaceutical company relationship means all payments come from one source, which may indicate a focused consulting or research relationship.

Drugs and Medical Devices Referenced in Payments

The following drugs and medical devices have been referenced in pharmaceutical payments to Dr. Eric Sanchez. These references indicate that the payment was related to the marketing, consulting, or clinical use of these products.

  • Spinraza -- Referenced in payment records from pharmaceutical companies to Dr. Eric Sanchez

The presence of a drug or device in a payment record means the pharmaceutical company associated the payment with that product. This is common for consulting fees related to a specific medication, speaking engagements about a product, or research involving a particular drug or device.

AI Transparency Analysis

The following analysis was generated by artificial intelligence based on Dr. Eric Sanchez's payment history, specialty peer comparisons, and payment pattern analysis. This analysis is not medical or legal advice.

Eric Sanchez has received $12.66 across 1 pharmaceutical payments as a Internal Medicine physician in Athens, GA. Top paying companies include Biogen ($12.66). Dr. Eric Sanchez received a single payment of $13 in 2026, which was for meals from Biogen for the treatment of Spinraza. The payment concentration from Biogen is 103%, indicating a high level of dependency on a single company.

Patient Guidance: Questions to Ask Your Doctor

If Dr. Eric Sanchez is your physician, here is practical guidance on how to understand and discuss pharmaceutical industry relationships:

Consumers should be aware that Dr. Eric Sanchez has received a single payment for a specific treatment, and it is advisable to seek multiple opinions for comprehensive care. Always feel free to ask your doctor directly about their pharmaceutical relationships.

Peer Comparison: How Dr. Eric Sanchez Compares to Other Internal Medicine Physicians

Compared to other Internal Medicine specialists, Dr. Eric Sanchez's payment amount is relatively low.

Recent Payment Records

The following table shows the most recent pharmaceutical industry payments recorded for Dr. Eric Sanchez in the CMS Open Payments database. Click on any payment to view the full report.

CompanyAmountTypeDrug/DeviceDateConflict Level
Biogen$12.66mealsSpinraza2026-03-08Not Assessed

Frequently Asked Questions About Dr. Eric Sanchez's Pharma Payments

Below are common questions patients ask about physician pharmaceutical payment data.

How much pharma money has Eric Sanchez received?

Eric Sanchez has received a total of $12.66 across 1 payments from pharmaceutical companies. This data is publicly reported under the CMS Open Payments (Sunshine Act) program.

Is Eric Sanchez taking too much pharma money?

Eric Sanchez has received $12.66 in pharmaceutical payments. Whether this is "too much" depends on the physician's specialty (Internal Medicine), the types of payments, and how they compare to peers. The largest payment category is meals ($12.66). Payment does not imply wrongdoing, but patients should be aware and can ask their doctor directly.

What pharma companies pay Eric Sanchez?

The top pharmaceutical companies paying Eric Sanchez are: Biogen ($12.66). These payments cover various categories including consulting, meals, speaking fees, and research grants.

What kinds of payments does Eric Sanchez receive?

Eric Sanchez's payments by type: meals: $12.66. Food and beverage is the most common payment type across all physicians.

Should I switch doctors because of pharma payments?

Pharma payments alone are not typically reason to switch doctors. Many payments are routine (like meals at educational events) and do not indicate compromised care. Focus on: (1) whether your doctor explains treatment options clearly, (2) whether generic alternatives are discussed, (3) the overall pattern of payments, not individual transactions. If you have concerns, ask your doctor directly.

How do Eric Sanchez's payments compare to other Internal Medicine doctors?

To compare, look at the total amount ($12.66), number of payments (1), and the types of payments received. Internal Medicine physicians may receive different payment amounts depending on subspecialty, geographic location, and academic affiliation. Use CMS Open Payments data to compare across the specialty.

How can I verify Eric Sanchez's payment data?

You can verify this data directly through the CMS Open Payments database at openpaymentsdata.cms.gov. Search by physician name or NPI number (1767530923). All data is reported by pharmaceutical companies and verified by CMS. DoctorPharmaData aggregates this public data for easier access.

Do pharma payments affect prescribing quality?

Research published in JAMA Internal Medicine and other peer-reviewed journals shows a statistical association between pharmaceutical payments and prescribing patterns. However, correlation does not equal causation. Many physician-industry interactions are legitimate (research, education, advisory boards). The Sunshine Act was created to promote transparency so patients can make informed decisions.

What stands out about Eric Sanchez's pharma payment profile?

The doctor received a single payment for a specific drug, Spinraza, from a single company, Biogen. Eric Sanchez has received $12.66 in total pharma payments.

How does Eric Sanchez compare to peers in Internal Medicine?

Compared to other Internal Medicine specialists, Dr. Eric Sanchez's payment amount is relatively low.

Are Eric Sanchez's pharma relationships typical for Internal Medicine?

The payment amount is relatively low at $13.

What should patients of Eric Sanchez know about these payments?

Consumers should be aware that Dr. Eric Sanchez has received a single payment for a specific treatment, and it is advisable to seek multiple opinions for comprehensive care.

What patterns are visible in Eric Sanchez's payment history?

The yearly trend shows a single payment in 2026, with no other data points available.

Understanding This Doctor Payment Report

This transparency report for Dr. Eric Sanchez is based on data from the CMS Open Payments database, which is maintained by the Centers for Medicare and Medicaid Services under the Physician Payments Sunshine Act. Here are important things to understand:

  • Payment does not imply wrongdoing. Many pharmaceutical payments represent legitimate professional activities such as consulting on drug development, speaking at medical education events, and conducting clinical research.
  • Context matters. A large payment for conducting a clinical trial has very different implications than a large payment for promotional speaking. The payment breakdown by category above provides this context.
  • Peer comparison is important. Whether a payment amount is unusual depends heavily on the physician's specialty, geographic location, and career stage. Internal Medicine physicians may have very different payment norms than physicians in other fields.
  • Data may be incomplete. The CMS Open Payments database captures payments from pharmaceutical and medical device manufacturers. It does not include payments from other sources, such as hospitals, insurance companies, or government agencies.
  • Reporting thresholds apply. Small payments below certain thresholds may not be individually reported. The totals reflect payments above reporting minimums set by CMS regulations.

About the Physician Payments Sunshine Act

The Physician Payments Sunshine Act, enacted as Section 6002 of the Affordable Care Act in 2010, requires pharmaceutical and medical device companies to report payments and other transfers of value to physicians and teaching hospitals to CMS. This law was designed to increase transparency in the financial relationships between the healthcare industry and medical providers.

Under this law, Dr. Eric Sanchez's pharmaceutical payments are publicly disclosed. The types of reportable transactions include consulting fees, compensated speaking or educational activities, honoraria, gifts, entertainment, food and beverages, travel and lodging, education or conference attendance, research grants, charitable contributions, royalties or licenses, current or prospective ownership interests, and direct compensation for services other than consulting.

The Open Payments data for Dr. Eric Sanchez and all other physicians can be accessed at the official CMS Open Payments website.

Other Internal Medicine Physicians

Compare Dr. Eric Sanchez's pharmaceutical payments with other Internal Medicine physicians ranked by total pharma payments received.

PhysicianStateTotal Payments
Karen HarrisAL$373,560.30
Andrew YoungMN$373,004.12
Catherine MorrisMI$329,087.36
Benjamin CookAL$290,577.64
Patricia DavisIN$229,890.74
Karen HarrisPA$223,458.75
Charles BakerOH$174,454.86
Amanda LewisTN$161,516.05
Amanda LewisAL$145,697.34
Christine EdwardsTX$144,283.94

Top Doctors in Georgia

These physicians in Georgia have received the highest pharmaceutical payments. See how Dr. Eric Sanchez compares to peers in the same state.

PhysicianSpecialtyTotal Payments
Kevin HillOphthalmology$314,311.18
Eric SanchezNeurology$274,975.98
Nicole LopezCardiology$242,466.83
Elizabeth RobertsPsychiatry$240,328.29
Laura HallNephrology$238,395.88
Rebecca AdamsNeurology$192,207.92
Elizabeth RobertsNeurology$155,098.53
Jeffrey CampbellNeurology$126,977.34
Scott CollinsPsychiatry$124,149.86
Patricia DavisRheumatology$117,342.00

Related Resources

Data from CMS Open Payments (Sunshine Act). Payment does not imply wrongdoing. AI analysis is not medical or legal advice. Consult your healthcare provider about any concerns.